Sponsor:
Novo Nordisk A/S
Code:
NCT06409130
Conditions
Alcohol-related Liver Disease
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
NNC0194-0499
Semaglutide
NNC0194-0499 placebo
Semaglutide placebo (Group A)
Cagrilintide + semaglutide
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations